{"organizations": [], "uuid": "c66455c96debe1297b221ac66a3aee5b4730b360", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://feeds.reuters.com/reuters/companyNews", "section_title": "Reuters: Company News", "url": "https://www.reuters.com/article/brief-pfizer-eu-approves-mylotarg-with-c/brief-pfizer-eu-approves-mylotarg-with-chemotherapy-to-treat-acute-myeloid-leukemia-idUSFWN1S00IF", "country": "US", "domain_rank": 408, "title": "BRIEF-Pfizer: EU Approves Mylotarg With Chemotherapy To Treat Acute Myeloid Leukemia", "performance_score": 0, "site": "reuters.com", "participants_count": 0, "title_full": "", "spam_score": 0.0, "site_type": "news", "published": "2018-04-23T14:48:00.000+03:00", "replies_count": 0, "uuid": "c66455c96debe1297b221ac66a3aee5b4730b360"}, "author": "", "url": "https://www.reuters.com/article/brief-pfizer-eu-approves-mylotarg-with-c/brief-pfizer-eu-approves-mylotarg-with-chemotherapy-to-treat-acute-myeloid-leukemia-idUSFWN1S00IF", "ord_in_thread": 0, "title": "BRIEF-Pfizer: EU Approves Mylotarg With Chemotherapy To Treat Acute Myeloid Leukemia", "locations": [], "entities": {"persons": [], "locations": [{"name": "eu", "sentiment": "none"}], "organizations": [{"name": "eu", "sentiment": "negative"}, {"name": "pfizer", "sentiment": "none"}, {"name": "treat acute myeloid leukemia reuters staff", "sentiment": "none"}, {"name": "pfizer inc", "sentiment": "none"}, {"name": "reuters", "sentiment": "none"}, {"name": "eikon", "sentiment": "none"}, {"name": "novo", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "April 23, 2018 / 11:50 AM / Updated 9 minutes ago BRIEF-Pfizer: EU Approves Mylotarg With Chemotherapy To Treat Acute Myeloid Leukemia Reuters Staff 1 Min Read \nApril 23 (Reuters) - Pfizer Inc: \n* MYLOTARGâ„¢ APPROVED IN THE EU FOR THE TREATMENT OF PREVIOUSLY UNTREATED, DE NOVO, CD33-POSITIVE ACUTE MYELOID LEUKEMIA IN COMBINATION WITH CHEMOTHERAPY \n* PFIZER - APPROVAL OF MYLOTARG BASED ON DATA FROM INVESTIGATOR-LED, PHASE 3 RANDOMIZED, OPEN-LABEL STUDY IN PREVIOUSLY UNTREATED, DE NOVO PATIENTS Source text for Eikon: Further company coverage: (Reuters.Briefs@thomsonreuters.com)", "external_links": [], "published": "2018-04-23T14:48:00.000+03:00", "crawled": "2018-04-23T15:05:15.044+03:00", "highlightTitle": ""}